Parliament Workbench

Question thread · 4 questions

What measures it is taking to encourage NHS boards not to use vaccines containing mercury.

Started with S2W-07038 on 18 Mar 2004; latest 12 May 2004. Each later question says it follows up an earlier answer.

Follow-ups
3
longest chain 2 steps
Span
55 days
18 Mar 2004 to 12 May 2004
Answered
4 of 4
by Malcolm Chisholm
Asked by
1
Carolyn Leckie

The thread, in order

Each answer’s opening lines; open a question for the full text
  1. S2W-07038 18 Mar 2004 Carolyn Leckie SSP Answered

    To ask the Scottish Executive what measures it is taking to encourage NHS boards not to use vaccines containing mercury.

    Malcolm Chisholm, 1 Apr 2004: The Joint Committee onVaccination and Immunisation (JCVI), a statutory independent expert advisorycommittee, advises UK health departments on matters relating tovaccination and immunisation. The UK Medicines andHealthcare products Regulatory Agency (MHRA), with advice from the independentexpert advisory committee, the…
  2. S2W-07671 22 Apr 2004 Carolyn Leckie SSP Answered

    Under what circumstances thiomersal would be removed from childhood vaccines as a precautionary measure and whether there are any plans to use the mercury-free vaccine, Infranrix, as an alternative to thiomersal.

    Malcolm Chisholm, 5 May 2004: As set out in the answer to questionS2W-7038 UK Health Departments are advised by a number of expert committees on mattersrelating to vaccination and immunisation and their advice, which has full regardto issues of safety and effectiveness is, and will continue to be, reflected inthe childhood vaccination programme. I…
  3. S2W-08104 7 May 2004 Carolyn Leckie SSP Answered follows S2W-07038

    Whether it will list all cases where thiomersal has been removed from vaccines as a precautionary measure.

    Malcolm Chisholm, 21 May 2004: The regulation and safety ofmedicines is reserved and is the responsibility of the Medicines and Healthcareproducts Regulatory Agency (MHRA). The MHRA has advised that since October 2003the following vaccines have had thiomersal removed from the manufacturing formulationof the bulk vaccine and consequently the finishe…
  4. S2W-08184 12 May 2004 Carolyn Leckie SSP Answered follows S2W-07671

    Whether it will provide further details of the scientific research and evidence to support the statement that the DTwP-Hib vaccine has been demonstrated to give more effective protection against whooping cough (pertussis) than the DTaP-Hib alternative, specifying the author, journal of publication and where the research was conducted.

    Malcolm Chisholm, 25 May 2004: The reasons for preferring highquality DTwP products over DTaP vaccine for primary immunisation are fully exploredin the paper Overview of Recent Clinical Trials of Acellular Pertussis Vaccines(Miller E) published in Biologicals (1999) Vol. 27; 79-86. This paper, whichis a review of trials conducted in Sweden, Italy, …

How this thread is put together

Follow-up
A question whose text says it is “further to the answer to question …” (or reply, response, or asks for a “substantive answer” to an earlier question). The question it names is its parent.
Several citations
When a question cites more than one earlier question, the most recent one we hold is used as the parent; the others are listed as “also cites”.
Thread
Follow parents back to the first question; every question that leads back to it is in this thread. Branches are shown in date order.

All question threads